Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases

Publication date: December 2021Source: Joint Bone Spine, Volume 88, Issue 6Author(s): Ludovic Trefond, Elodie Drumez, Marc Andre, Nathalie Costedoat-Chalumeau, Raphaèle Seror, Mathilde Devaux, Emmanuelle Dernis, Yannick Dieudonné, Soumaya El Mahou, Aurelia Lanteri, Isabelle Melki, Viviane Queyrel, Mathilde Roumier, Jean Schmidt, Thomas Barnetche, Thierry Thomas, Patrice Cacoub, Alexandre Belot, Olivier Aumaitre, Christophe Richez
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research